We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
301
Expeditors International
EXPD
$23.1B
$60K 0.07%
790
-3,222
-80% -$235K
MTG icon
302
MGIC Investment
MTG
$6.3B
$60K 0.07%
7,271
+6,456
+792% +$48.3K
ENPH icon
303
Enphase Energy
ENPH
$5.55B
$59K 0.07%
1,234
+194
+19% +$9.27K
CPB icon
304
Campbell Soup
CPB
$6.75B
$58K 0.07%
1,178
-5,754
-83% -$286K
MRCY icon
305
Mercury Systems
MRCY
$6.53B
$58K 0.07%
+738
New +$60.4K
UHS icon
306
Universal Health Services
UHS
$10B
$58K 0.07%
+622
New +$62.2K
ANSS
307
DELISTED
Ansys
ANSS
$57K 0.07%
+197
New +$52.5K
FR icon
308
First Industrial Realty Trust
FR
$8.38B
$57K 0.07%
+1,477
New +$54K
TRIP icon
309
TripAdvisor
TRIP
$1.28B
$57K 0.07%
3,017
-181
-6% -$3.46K
NEM icon
310
Newmont
NEM
$123B
$55K 0.06%
+898
New +$53.2K
PB icon
311
Prosperity Bancshares
PB
$8.9B
$55K 0.06%
+923
New +$53.3K
RPRX icon
312
Royalty Pharma
RPRX
$26B
$54K 0.06%
+1,102
New +$54.5K
ARMK icon
313
Aramark
ARMK
$15.9B
$53K 0.06%
3,249
+2,678
+469% +$47K
CPA icon
314
Copa Holdings
CPA
$5.51B
$53K 0.06%
1,045
+745
+248% +$34.4K
FIVN icon
315
FIVE9
FIVN
$2.49B
$53K 0.06%
+480
New +$46.7K
CHGG icon
316
Chegg
CHGG
$93.1M
$52K 0.06%
768
+19
+3% +$1.01K
RDN icon
317
Radian Group
RDN
$4.91B
$52K 0.06%
3,341
-1,236
-27% -$18.3K
SJM icon
318
J.M. Smucker
SJM
$12.6B
$52K 0.06%
492
+339
+222% +$38.1K
APA icon
319
APA Corp
APA
$14.4B
$51K 0.06%
3,776
-933
-20% -$10.6K
IRBT
320
DELISTED
iRobot
IRBT
$51K 0.06%
+610
New +$40.2K
TXRH icon
321
Texas Roadhouse
TXRH
$13.9B
$51K 0.06%
+977
New +$47.6K
DOC
322
DELISTED
PHYSICIANS REALTY TRUST
DOC
$51K 0.06%
2,899
-2,330
-45% -$38K
BYND icon
323
Beyond Meat
BYND
$213M
$50K 0.06%
+374
New +$44.3K
HUBS icon
324
HubSpot
HUBS
$11B
$50K 0.06%
+222
New +$39.9K
TRN icon
325
Trinity Industries
TRN
$2.3B
$50K 0.06%
+2,363
New +$45.5K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.